KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹120 Cr | ₹108 Cr | ₹93 Cr | ₹80 Cr | ₹62 Cr |
What is the latest Revenue of KERALA AYURVEDA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹108 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹62 Cr |
How is Revenue of KERALA AYURVEDA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | 11.57 | |
| Mar2024 | ₹108 Cr | 15.46 | |
| Mar2023 | ₹93 Cr | 16.25 | |
| Mar2022 | ₹80 Cr | 29.45 | |
| Mar2021 | ₹62 Cr | - | |
Compare Revenue of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹226.5 Cr | 0.3% | 12.1% | -63.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | 0.3% |
12.1% |
-63.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses